These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25003381)

  • 1. Influence of the polypeptide environment next to amyloidogenic peptides on fibril formation.
    Damm S; Schwarz E
    Biol Chem; 2014 Jul; 395(7-8):699-709. PubMed ID: 25003381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different morphology of amyloid fibrils originating from agitated and non-agitated conditions.
    Buttstedt A; Wostradowski T; Ihling C; Hause G; Sinz A; Schwarz E
    Amyloid; 2013 Jun; 20(2):86-92. PubMed ID: 23570235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R; Caflisch A
    J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.
    Milton NG; Harris JR
    Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of kinetic pathways in amyloid fibril formation.
    Bellesia G; Shea JE
    J Chem Phys; 2009 Sep; 131(11):111102. PubMed ID: 19778093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of Aggregation-Prone Segments is the Requirement for Amyloid Fibril Formation.
    Pramanik S; Ahmad B
    Curr Protein Pept Sci; 2018; 19(10):1024-1035. PubMed ID: 29779477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.
    Margittai M; Langen R
    Q Rev Biophys; 2008; 41(3-4):265-97. PubMed ID: 19079806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning the conformational properties of the prion peptide.
    Ho CC; Lee LY; Huang KT; Lin CC; Ku MY; Yang CC; Chan SI; Hsu RL; Chen RP
    Proteins; 2009 Jul; 76(1):213-25. PubMed ID: 19137620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology.
    Marek P; Abedini A; Song B; Kanungo M; Johnson ME; Gupta R; Zaman W; Wong SS; Raleigh DP
    Biochemistry; 2007 Mar; 46(11):3255-61. PubMed ID: 17311418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of amyloid fibrils from β-amylase.
    Luo JC; Wang SC; Jian WB; Chen CH; Tang JL; Lee CI
    FEBS Lett; 2012 Mar; 586(6):680-5. PubMed ID: 22449963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool.
    Gazit E
    FEBS J; 2005 Dec; 272(23):5971-8. PubMed ID: 16302962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
    Legge FS; Binger KJ; Griffin MD; Howlett GJ; Scanlon D; Treutlein H; Yarovsky I
    J Phys Chem B; 2009 Oct; 113(42):14006-14. PubMed ID: 19780547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin promotes the rapid fibrillization of a peptide with low intrinsic amyloidogenicity.
    Madine J; Davies HA; Hughes E; Middleton DA
    Biochemistry; 2013 Dec; 52(50):8984-92. PubMed ID: 24279288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains.
    DuBay KF; Pawar AP; Chiti F; Zurdo J; Dobson CM; Vendruscolo M
    J Mol Biol; 2004 Aug; 341(5):1317-26. PubMed ID: 15302561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dissociated form of kappa-casein is the precursor to its amyloid fibril formation.
    Ecroyd H; Thorn DC; Liu Y; Carver JA
    Biochem J; 2010 Jul; 429(2):251-60. PubMed ID: 20441567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects on human amyloid forms and their fibril polypeptides.
    Westermark P
    FEBS J; 2005 Dec; 272(23):5942-9. PubMed ID: 16302959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural polymorphism and possible pathways of amyloid fibril formation on the example of insulin protein.
    Selivanova OM; Galzitskaya OV
    Biochemistry (Mosc); 2012 Nov; 77(11):1237-47. PubMed ID: 23240561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.